Chagas disease screening in the French blood donor population. Screening assays and donor selection

Enfermedades Emergentes

Volumn 9, Issue SUPPL. 1, 2007, Pages 38-40

  Assal, A ^a   Aznar, C ^b  

^a French Blood Services   (French Guiana)

^b CH/UFR Médecine EA 3593 ^*  (French Guiana)

Author keywords

Blood donors; Trypanosoma cruzi screening

Indexed keywords

BLOOD ANALYSIS; BLOOD DONOR; CHAGAS DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCE; HIGH RISK POPULATION; HUMAN; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; SCREENING TEST; SENSITIVITY ANALYSIS; SEROLOGY;

EID: 34147153503     PISSN: 15754723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, et al. Transfusion associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 2006;46:298-304.
2. Pirard M, Lihoshi N, Boelaert M, et al. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005;45:554-61.
3. Andrade AL, Martelli CM, Luquetti AO, et al. Serologic screening for Trypanosoma cruzi among blood donors in central Brazil. Bull Pan Am Health Organ 1992;26:157-64.
4. Luquetti AO. Use of Trypanosoma defined proteins for diagnosis - Multicentre Trial. Serological and technical aspects. Mem Inst Oswaldo Cruz 1990;85:497-505.